Skip navigation

Plant-derived anticancer agents: Lessons from the pharmacology of geniposide and its aglycone, genipin

Plant-derived anticancer agents: Lessons from the pharmacology of geniposide and its aglycone, genipin

Habtemariam, Solomon and Lentini, Giovanni (2018) Plant-derived anticancer agents: Lessons from the pharmacology of geniposide and its aglycone, genipin. Biomedicines, 6 (2):39. ISSN 2227-9059 (Online) (doi:https://doi.org/10.3390/biomedicines6020039)

[img]
Preview
PDF (Publisher's PDF - Open Access)
21806 HABTEMARIAM_Plant-Derived_Anticancer_Agents_(OA)_2018.pdf - Published Version
Available under License Creative Commons Attribution.

Download (14MB) | Preview

Abstract

For centuries, plants have been exploited by mankind as sources of numerous cancer chemotherapeutic agents. Good examples of anticancer compounds of clinical significance today include the taxanes (e.g., taxol), vincristine, vinblastine, and the podophyllotoxin analogues that all trace their origin to higher plants. While all these drugs, along with the various other available therapeutic options, brought some relief in cancer management, a real breakthrough or cure has not yet been achieved. This critical review is a reflection on the lessons learnt from decades of research on the iridoid glycoside geniposide and its aglycone, genipin, which are currently used as gold standard reference compounds in cancer studies. Their effects on tumour development (carcinogenesis), cancer cell survival, and death, with particular emphasis on their mechanisms of actions, are discussed. Particular attention is also given to mechanisms related to the dual pro-oxidant and antioxidant effects of these compounds, the mitochondrial mechanism of cancer cell killing through reactive oxygen species (ROS), including that generated through the uncoupling protein-2 (UCP-2), the inflammatory mechanism, and cell cycle regulation. The implications of various studies for the evaluation of glycosidic and aglycone forms of natural products in vitro and in vivo through pharmacokinetic scrutiny are also addressed.

Item Type: Article
Additional Information: © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Uncontrolled Keywords: cancer; carcinogenesis; metastasis; genipin; geniposide; reactive oxygen species; apoptosis; uncoupling protein 2
Subjects: R Medicine > RM Therapeutics. Pharmacology
Faculty / Department / Research Group: Faculty of Engineering & Science
Faculty of Engineering & Science > School of Science (SCI)
Last Modified: 11 Oct 2018 12:07
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: None
Selected for GREAT 2019: None
Selected for REF2021: None
URI: http://gala.gre.ac.uk/id/eprint/21806

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics